

[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
Douglas Tsao Initiated (XENE) at Strong Buy and Held Target at $53 on, Oct 1st, 2024
Douglas Tsao of HC Wainwright & Co., Initiated "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy and Held Target at $53 on, Oct 1st, 2024.
Douglas has made no other calls on XENE in the last 4 months.
There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Douglas's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Douglas
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Tuesday, September 3rd, 2024
- Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $60 on, Monday, August 12th, 2024
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Friday, August 9th, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $49 on, Friday, August 9th, 2024
Contributing Sources